Prostate sarcomas are extremely rare tumors, usually presenting with a large obstructive mass and normal levels of prostate-specific antigen (PSA), with an aggressive outcome and poor prognosis, so early recognition and surgical treatment with curative intent offer patients the best chance of survival [3]. This evidence concerns the gene KLK3 and prostate sarcoma.